Marcellin, PatrickButi, MariaKrastev, ZaharyGermanidis, GeorgeKaita, Kelly D.Kotzev, IskrenBuggisch, PeterWeilert, FrankTrinh, Huy N.Heathcote, E. JennySorbel, JeffAnderson, JaneMondou, ElsaRousseau, Franck2022-05-302022-05-302009-10Marcellin, P. vd. (2009) "Three years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102); preliminary analysis". Hepatology, 50(4), 532A-533A.0270-9139http://hdl.handle.net/11452/26768Bu çalışma, 30 Ekim-03 Kasım 2009 tarihleri arasında Boston[Massachusetts]’da düzenlenen 60. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.Amer Assoc Study Liver Diseninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyThree years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102); preliminary analysisMeeting Abstract000270456000482532A533A504Gastroenterology & hepatology